NEW YORK, Oct. 9 - Genaissance Pharmaceuticals has licensed certain data from its haplotype library to drug giant Pfizer, Genaissance said on Tuesday.

Financial terms of the deal were not disclosed.

Genaissance, based in New Haven, Conn., has already identified roughly 80,000 haplotypes from almost 5,000 genes and says it intends to discover haplotypes across the entire genome.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.